These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 9329569)
1. Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance. Gebauer G; Müller-Ruchholtz W Anticancer Res; 1997; 17(4B):2939-42. PubMed ID: 9329569 [TBL] [Abstract][Full Text] [Related]
2. Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance. Gebauer G; Müller-Ruchholtz W Anticancer Res; 1997; 17(4A):2731-4. PubMed ID: 9252706 [TBL] [Abstract][Full Text] [Related]
3. Carcinoembryonic antigen and CA19-9: implications of quantitative marker measurement in tissues for prognosis of colorectal cancer. Gebauer G; Müller-Ruchholtz W Cancer Detect Prev; 2001; 25(4):344-51. PubMed ID: 11531011 [TBL] [Abstract][Full Text] [Related]
4. Slope analysis of CA19-9 and CEA for predicting recurrence in colorectal cancer patients. Nakayama T; Watanabe M; Teramoto T; Kitajima M Anticancer Res; 1997; 17(2B):1379-82. PubMed ID: 9137502 [TBL] [Abstract][Full Text] [Related]
5. The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence. Holubec L; Topolcan O; Pikner R; Pecen L; Vaclavickova J; Wirthova M; Molacek J; Stieber P; Holdenrieder S; Sen LH; Finek J Anticancer Res; 2000; 20(6D):5237-44. PubMed ID: 11326702 [TBL] [Abstract][Full Text] [Related]
6. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of serum tumor antigen CA19-9 after curative resection of colorectal cancer. Park IJ; Choi GS; Jun SH Anticancer Res; 2009 Oct; 29(10):4303-8. PubMed ID: 19846991 [TBL] [Abstract][Full Text] [Related]
8. N(1),N(12)-Diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers. Hiramatsu K; Takahashi K; Yamaguchi T; Matsumoto H; Miyamoto H; Tanaka S; Tanaka C; Tamamori Y; Imajo M; Kawaguchi M; Toi M; Mori T; Kawakita M Clin Cancer Res; 2005 Apr; 11(8):2986-90. PubMed ID: 15837752 [TBL] [Abstract][Full Text] [Related]
9. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Lai IR; Lee WJ; Huang MT; Lin HH Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226 [TBL] [Abstract][Full Text] [Related]
10. [Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer]. Grotowski M Pol Merkur Lekarski; 2002 Jan; 12(67):77-80. PubMed ID: 11957811 [TBL] [Abstract][Full Text] [Related]
11. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244 [TBL] [Abstract][Full Text] [Related]
12. Tumor markers in patients with relapse of colorectal carcinoma. Lipská L; Visokai V; Levý M; Svobodová S; Kormunda S; Fínek J Anticancer Res; 2007; 27(4A):1901-5. PubMed ID: 17649792 [TBL] [Abstract][Full Text] [Related]
13. Preoperative serum level of CA19-9 predicts recurrence after curative surgery in node-negative colorectal cancer patients. Nakagoe T; Sawai T; Tsuji T; Jibiki MA; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K Hepatogastroenterology; 2003; 50(51):696-9. PubMed ID: 12828063 [TBL] [Abstract][Full Text] [Related]
14. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of carcinoembryonic antigen (CEA) in tumor tissue of patients with colorectal cancer. Nakagoe T; Sawai T; Ayabe H; Nakazaki T; Ishikaw H; Hatano K; Kajiwara K; Miyashita K; Matsuo T; Nogawa T; Arisawa K Anticancer Res; 2001; 21(4B):3031-6. PubMed ID: 11712806 [TBL] [Abstract][Full Text] [Related]
16. Tumor markers in staging and prognosis of colorectal carcinoma. Levy M; Visokai V; Lipska L; Topolcan O Neoplasma; 2008; 55(2):138-42. PubMed ID: 18237252 [TBL] [Abstract][Full Text] [Related]
17. [Detection and clinical study of serum tumor markers in patients with colorectal cancer]. Zhao XW; Jiang B; Han CZ; Jing JX Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):286-8. PubMed ID: 15996321 [TBL] [Abstract][Full Text] [Related]
18. [Prognostic study of preoperative serum levels of CEA and CA 19-9 in colorectal cancer]. Uehara M; Manaka D; Baba S; Oji Y; Hirata K; Shimizu M; Noguchi M Gan To Kagaku Ryoho; 2007 Sep; 34(9):1413-7. PubMed ID: 17876139 [TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer. Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733 [TBL] [Abstract][Full Text] [Related]
20. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases. Chen C; Chen LQ; Yang GL; Li Y Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]